ArticleExperimental & molecular medicine2023

Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema.

Jung-Jin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.